Skip to main content

Recro Pharma Inc (NASDAQ: REPH) Investor Securities Class Action Lawsuit 05/31/2018

  • If you purchased shares of Recro Pharma Inc (NASDAQ: REPH), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 1, 2021 - The court denied the defendants' motion to dismiss. June 18, 2020 - A motion to dismiss the second amended complaint was filed. April 24, 2020 - A second amended complaint was filed. February 14, 2020 - The court granted the defendants' motion to dismiss. The plaintiffs were given leave to amend the complaint. February 8, 2019 - A motion to dismiss the amended complain...



You must register (for free) or login to view the entire case.